- Panduan Umum Permohonan ePermit Import Dan Eksport Yang Dikeluarkan Oleh BPF, KKM
- Bahagian Perkhidmatan Farmasi Negeri
- Retroviral Disease (RVD) Pharmacy Services Protocol: Adult and Paediatric (Edisi Ketiga)
- Senarai ubat Galenikal Dan Ekstemporaneous (GAEX) dalam Sistem PhIS
- Dokumen Permohonan Cuti Belajar
Hubungi Kami
Lot 36,
Jalan Universiti (Jalan Prof Diraja Ungku Aziz),
46200 Petaling Jaya, Selangor.
[ Peta Lokasi ]
Tel: 603-7841 3200
Faks: 603-7968 2222
Anda di sini
Search
Dipaparkan jumlah carian 141 - 150 daripada 1542
Company is allowed to apply for amendment to the advertisement approved by Medicine Advertisements Board within two (2) months from the date of approval. Company may submit the application by fill in...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
Menurut Peraturan 4(1) Peraturan-peraturan Lembaga Iklan Ubat 1976, Lembaga Iklan Ubat mempunyai kuasa untuk menentukan prosedur sendiri dalam meluluskan iklan. Sebelum tahun 2012, semua permohonan...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
According to R4(1) MABR 1976, the Board have the power to regulate its own procedure in approving advertisement. Before the year 2012, all application of approval was being processed and approved in...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
Ya, pernyataan yang pernah diluluskan oleh LIU tidak akan dibenarkan dalam permohonan kelulusan iklan yang baru sekiranya pernyataan tersebut melampaui skop indikasi yang diluluskan oleh PBKD,...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
Yes, claims that were previously approved will not be allowed in new application of approval if it is beyond the indication approved by DCA as stipulated in MAB policy MAB 3/2017 Claims. According to...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
Berdasarkan Polisi dan Keputusan Lembaga Iklan Ubat MAB 3/2017 dan Perenggan 5.2 Garis Panduan Kelulusan Pengiklanan Produk Ubat Berdaftar, tuntutan yang dibuat dalam iklan mestilah mengikut indikasi...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
Referring Medicine Advertisements Board Policy and Decision MAB 3/2017 and Paragraph 5.2 Registered Medicinal Products Advertising Approval Guideline, claims made in an advertisement must be in...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
Ubat terkawal yang diperolehi daripada pengamal perubatan berdaftar, doktor gigi berdaftar atau ahli farmasi berlesen/berdaftar bagi tujuan rawatan pesakit di kategorikan sebagai racun kumpulan B dan...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
The controlled medicine obtained from registered medical practitioners, registered dentists, or licensed/ registered pharmacists for the purpose of treating patients is categorized as Group B and C...
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024
Advertisements for supplement products, Over-The-Counter (OTC) products and traditional products that have been registered with Drug Control Authority (DCA) require approval from MAB.
Kategori: Soalan Lazim | Tarikh: 09 Feb 2024




